Dasatinib Tablet
Product Images NDC 59651-547

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Dasatinib (NDC 59651-547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg (60 Tablet Bottle))

Dasatinib Tablets 20 mg label for an oral human prescription drug by Aurobindo Pharma Limited. The label indicates a 60-tablet bottle, includes dosage and storage instructions, warnings against crushing or chewing the tablets, and distribution information for Aurobindo Pharma USA, Inc. The label design features a barcode and a designated coding area.*

FDA Label Image

Package Label-principal Display Panel (100 mg 15 (1x15) Unit-dose Tablets)

Packaging label for Dasatinib Tablets 100 mg oral tablets by Aurobindo Pharma Limited. The unit-dose package contains 15 tablets (1 x 15). The label includes storage instructions, dosage reference to package insert, and a note that the package is not child resistant. Distributed by Aurobindo Pharma USA, Inc., made in India.*

FDA Label Image

Package Label-principal Display Panel (140 mg (30 Tablet Bottle))

Label for Dasatinib Tablets 140 mg oral tablets by Aurobindo Pharma USA, Inc. The label shows the NDC 59651-547-30 and states the package contains 30 tablets. Instructions include swallowing tablets whole and not crushing, cutting, or chewing. Storage conditions and distributor details in East Windsor, NJ, are also visible.*

FDA Label Image

Package Label-principal Display Panel (140 mg 15 (1x15) Unit-dose Tablets)

Dasatinib Tablets 140 mg oral tablet packaging label from Aurobindo Pharma Limited. The label states each film-coated tablet contains 140 mg of dasatinib. It includes instructions to swallow tablets whole without crushing, cutting, or chewing. The package contains 15 unit-dose tablets (1 x 15) and is marked Rx only. Storage instructions specify 20° to 25°C with allowable excursions. Distributed by Aurobindo Pharma USA, made in India.*

FDA Label Image

Package Label-principal Display Panel (20 mg 15 (1x15) Unit-dose Tablets)

Dasatinib Tablets 20 mg oral tablets packaging label from Aurobindo Pharma. The label shows a unit-dose carton containing 15 tablets (1x15) with dosing instructions, storage conditions, and handling warnings. The label includes the NDC code 59651-542-15 and states the product is manufactured in India and distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))

Label for Dasatinib Tablets 50 mg, oral dosage form, containing 60 film-coated tablets. Distributed by Aurobindo Pharma USA, Inc. with manufacturing in India. The label includes usage cautions such as swallowing tablets whole and storage instructions at controlled room temperature. The NDC number 59651-543-60 is shown along with a barcode.*

FDA Label Image

Package Label-principal Display Panel (50 mg 15 (1x15) Unit-dose Tablets)

Dasatinib Tablets 50 mg film-coated tablets in a 15 unit-dose package. The label includes storage instructions, dosage references to the package insert, and a warning not to crush, cut, or chew tablets. Distributed by Aurobindo Pharma USA, Inc., made in India, with NDC 59651-543-15.*

FDA Label Image

Package Label-principal Display Panel (70 mg (60 Tablet Bottle))

Label for Dasatinib Tablets 70 mg oral tablets by Aurobindo Pharma Limited. The label shows a package size of 60 tablets, with instructions not to crush, cut, or chew tablets. It lists storage conditions, distributor information (Aurobindo Pharma USA, Inc., East Windsor, NJ), and states the product is made in India. Barcode and NDC 59651-544-60 are also visible.*

FDA Label Image

Package Label-principal Display Panel (70 mg 15 (1x15) Unit-dose Tablets)

Dasatinib Tablets 70 mg oral tablet packaging label from Aurobindo Pharma Limited. The label states the dosage strength of 70 mg and includes instructions not to crush, cut, or chew the tablets. The carton contains 15 unit-dose tablets in one blister pack. Storage conditions and manufacturer information are also displayed.*

FDA Label Image

Package Label-principal Display Panel (80 mg (30 Tablet Bottle))

Label for Dasatinib Tablets 80 mg, a prescription oral tablet. Contains 30 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India. Includes storage instructions and a warning not to crush, cut or chew tablets. NDC 59651-545-30 shown with color and printing details.*

FDA Label Image

Package Label-principal Display Panel (80 mg 15 (1x15) Unit-dose Tablets)

Dasatinib Tablets 80 mg oral tablets packaging label from Aurobindo Pharma Limited. The label includes dosage instructions, storage conditions, and a 15-unit dose tablet count. The design features the Aurobindo logo and states the product is prescription only (Rx only). It also mentions the package is not child resistant and advises to swallow tablets whole without crushing or chewing.*

FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))

Dasatinib Tablets 100 mg film-coated tablets label showing the quantity of 30 tablets per package. Label includes storage instructions, dosage warnings, and distributor information for Aurobindo Pharma USA, Inc. The label also features the brand Aurobindo logo and a barcode.*

FDA Label Image

Chemical-structure (Dasatinib Str)

Chemical structure of dasatinib, showing its molecular framework with atoms and bonds representing the compound's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.